Stay updated on Intradermal IMO-2125 in T3-4 Melanoma Clinical Trial
Sign up to get notified when there's something new on the Intradermal IMO-2125 in T3-4 Melanoma Clinical Trial page.

Latest updates to the Intradermal IMO-2125 in T3-4 Melanoma Clinical Trial page
- ChecktodayChange DetectedA new revision entry v3.5.5 was added to the study's history, replacing the previous v3.5.4 in the page's version history.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe footer revision label was updated from v3.5.3 to v3.5.4, indicating a new release of the site's interface. This change represents a software version update rather than changes to the study record content.SummaryDifference0.1%

- Check43 days agoChange DetectedThe page’s displayed site revision version was updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check50 days agoChange DetectedRevision v3.5.2 was added and revision v3.5.0 was removed from the study record history.SummaryDifference0.1%

- Check79 days agoChange DetectedRevision 3.5.0 was added to the history. Revision 3.4.3 was removed from the history.SummaryDifference0.1%

- Check86 days agoChange DetectedRevision v3.4.3 was added and revision v3.4.2 was removed from the record history.SummaryDifference0.1%

Stay in the know with updates to Intradermal IMO-2125 in T3-4 Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intradermal IMO-2125 in T3-4 Melanoma Clinical Trial page.